drugset

drugset / Trial / NCT00304161

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

NCT00304161 ↗

Phase 4 Completed 55 enrolled University of Pennsylvania National Institute of Mental Health (NIMH) · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness of atomoxetine in reducing symptoms of depression in people with Parkinson's disease.

Timeline

Start: 2004-07
Primary completion: 2008-12
Completion: 2008-12

Publications

Results Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Nazem S, Ten Have TR, Stern MB. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology. 2010 Aug 3;75(5):448-55. doi: 10.1212/WNL.0b013e3181ebdd79.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Atomoxetine	Other / unclassified	80 mg	Oral

Indications